Friday, 05.02.08
Lethal Injection
|
|
For those scared or curious enough to pay attention, this week's hearings offered a jarring look at how globalization is affecting the medicines we take. True, some testimony was predictable: the FDA denied that it could have averted the tragedy with an earlier (and required) inspection of the suspect Chinese factory; Baxter's CEO played the victim card, claiming that his firm's heparin, an anticoagulant, was the target of a deliberate adulteration scheme. (The Chinese government, meanwhile, argued that the faulty ingredients weren't to blame for the deaths.) But the statement of David Nelson, the senior investigator of the committee holding the hearings, sandblasts the varnish off such evasions, especially Baxter's dubious behavior, and is worth a read. MORE |
![]() | |


